Skip to main content
. 2024 Jun 8;31(9):6088–6096. doi: 10.1245/s10434-024-15569-2

Table 1.

Baseline characteristicsa

Observation Radiotherapy Overall
(n = 23) n (%) (n = 27) n (%) (n = 50) n (%)
Primary site
Forehead or temple 2 (8.7) 4 (14.8) 6 (12.0)
Midface 4 (17.4) 7 (25.9) 11 (22.0)
Postauricular 0 1 (3.7) 1 (2.0)
Lip or chin 4 (17.4) 6 (22.2) 10 (20.0)
Scalp 9 (39.1) 7 (25.9) 16 (32)
Neck 4 (17.4) 2 (7.4) 6 (12)
Primary thickness (mm)
Median (range) 5.0 (1.1–15.0) 5.2 (2.0–14.0) 5.0 (1.1–15.0)
Clark level
III 1 (4.5) 0 1 (2.1)
IV 7 (31.8) 5 (20) 12 (25.5)
V 12 (54.5) 20 (80) 32 (68.1)
Unknown 3 (13.0) 2 (7.4) 5 (10)
Perineural invasion
Unifocal 5 (22) 8 (30) 13 (26)
Multifocal 9 (39) 10 (37) 19 (38)
Unknown 9 (39) 9 (33) 18 (36)
Largest involved nerve diameter (mm)
Median (range) 0.1 (0.05–0.2) 0.07 (0.04–4) 0.1 (0.04–4.0)
Unknown 17 (74) 14 (52) 31 (62)
Ulceration
Present 8 (34.8) 5 (18.5) 13 (26.0)
Microsatellites
Present 1 (4.3) 1 (3.7) 2 (4.0)
Desmoplasia
Present 13 (56.5) 21 (80.8) 34 (69.4)
Mitotic number (per mm2)
Median (range) 3.5 (0.0–18.0) 3.0 (1.0–26.0) 3.0 (0.0–26.0)
Excision margin clearance (mm)
Lateral: median (range) 7.0 (0.1–45.0) 10.0 (0.3–45.7) 9.5 (0.1–45.7)
Deep: median (range) 3.0 (0.1–13.0) 1.2 (0.1–11.0) 2.0 (0.1–13.0)
Missing 5 (23) 3 (11) 8 (16)

aMidface includes cheek, nose, pinna, preauricular